Anika Therapeutics, Inc. (NASDAQ:ANIK)

CAPS Rating: 3 out of 5

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Recs

1
Player Avatar acts20 (34.75) Submitted: 9/30/2011 10:11:30 AM : Outperform Start Price: $5.41 ANIK Score: +137.48

Ceo sucks. But at low. Buy out prospect. New products

Report this Post Reply

Featured Broker Partners


Advertisement